Corcept Therapeutics Incorporated (CORT)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	664,158	475,894	396,473	360,697	348,292
Revenue	US$ in thousands	675,040	482,375	401,858	365,978	353,874
Gross profit margin		98.39%	98.66%	98.66%	98.56%	98.42%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $664,158K ÷ $675,040K
= 98.39%

The gross profit margin of Corcept Therapeutics Incorporated has shown a generally stable trend over the past five years, ranging from 98.39% to 98.66%. This indicates that the company is effectively managing its production costs and generating a high percentage of revenue after deducting the cost of goods sold. The consistently high gross profit margin suggests strong pricing power, efficient operations, and possibly a competitive advantage in the industry. However, there was a slight decrease in the gross profit margin in December 31, 2024, compared to the previous year. It would be essential for the company to monitor and analyze the factors contributing to this decrease to ensure continued profitability and long-term success.